Who owns UPB?
Institutional ownership of Upstream Bio Inc. from Form 13F, Q2 2026
149 institutional managers reported holding Upstream Bio Inc. (UPB) in Form 13F filings for Q2 2026, with 50,573,705 shares worth $350M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 5,689,204 shares (+12.7%). 37 opened new positions and 28 sold out.
- Funds holding
- 149
- Value held
- $350M
- New / sold out
- 37 / 28
- Net shares, same filers
- +12.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of UPB
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $56.5M | 16.1% | 8,162,897 | Added |
| Orbimed Advisors LLC | $39.4M | 11.3% | 5,693,589 | Unchanged |
| Norges Bank | $26.1M | 7.5% | 3,768,619 | New |
| BlackRock, Inc. | $26.0M | 7.4% | 3,753,358 | Added |
| Decheng Capital LLC | $18.9M | 5.4% | 2,724,868 | Unchanged |
| Enavate Sciences GP, LLC | $17.0M | 4.9% | 2,459,703 | Unchanged |
| Vanguard Capital Management LLC | $13.0M | 3.7% | 1,876,734 | Added |
| Millennium Management LLC | $7.9M | 2.3% | 1,143,775 | Added |
| D. E. Shaw & Co., Inc. | $7.2M | 2.0% | 1,036,044 | Added |
| JPMorgan Chase & Co | $7.0M | 2.0% | 1,012,044 | Added |
| Qube Research & Technologies Ltd | $6.8M | 1.9% | 978,500 | Added |
| Parkman Healthcare Partners LLC | $6.5M | 1.8% | 935,247 | Added |
| Geode Capital Management, LLC | $6.4M | 1.8% | 931,261 | Trimmed |
| SEB Asset Management AB | $6.1M | 1.7% | 878,473 | Unchanged |
| Woodline Partners LP | $5.8M | 1.6% | 831,481 | Unchanged |
| State Street Corp | $5.3M | 1.5% | 766,323 | Added |
| Vanguard Portfolio Management LLC | $4.9M | 1.4% | 712,667 | Trimmed |
| Y-Intercept (Hong Kong) Ltd | $4.8M | 1.4% | 693,555 | Trimmed |
| Bain Capital Life Sciences Investors, LLC | $4.2M | 1.2% | 600,949 | Trimmed |
| AQR Capital Management LLC | $3.8M | 1.1% | 544,869 | Added |
| Morgan Stanley | $3.6M | 1.0% | 524,632 | Trimmed |
| BNP Paribas Financial Markets | $3.5M | 1.0% | 511,546 | Added |
| Walleye Capital LLC | $3.4M | 1.0% | 498,490 | New |
| Trexquant Investment LP | $3.2M | 0.9% | 466,430 | Added |
| Point72 Asset Management, L.P. | $3.1M | 0.9% | 453,011 | Added |
Share of 13F holdings is each fund's shares as a share of the 50,573,705 UPB shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Norges Bank New+$26.1M
- JPMorgan Chase & Co Added+$3.8M
- Walleye Capital LLC New+$3.4M
- AQR Capital Management LLC Added+$3.3M
- BNP Paribas Financial Markets Added+$2.7M
- BlackRock, Inc. Added+$2.6M
- Qube Research & Technologies Ltd Added+$2.5M
- Bank of America Corp Added+$2.4M
- Dimensional Fund Advisors LP Added+$2.1M
- Trexquant Investment LP Added+$2.0M
Biggest sellers in Q2 2026
- Federated Hermes, Inc. Sold out-$8.8M
- Pictet Asset Management Holding SA Sold out-$6.6M
- HSBC Holdings PLC Trimmed-$4.5M
- Nantahala Capital Management, LLC Sold out-$3.6M
- Alyeska Investment Group, L.P. Sold out-$2.7M
- Samsara Biocapital, LLC Trimmed-$2.6M
- Prosight Management, LP Sold out-$2.2M
- Y-Intercept (Hong Kong) Ltd Trimmed-$2.1M
- Bain Capital Life Sciences Investors, LLC Trimmed-$1.8M
- TCG Crossover Management, LLC Sold out-$1.6M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $75.4M and sold $42.7M; 65 added and 28 trimmed.
Schedule 13D and 13G filings on UPB
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-30BlackRock, Inc. SCHEDULE 13G filed by Upstream Bio Inc.Schedule 13G
- 2025-10-24NORGES BANK SCHEDULE 13G filed by Upstream Bio Inc.Schedule 13G
- 2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P. SCHEDULE 13G filed by Upstream Bio Inc.Schedule 13G
- 2025-02-14TCG Crossover GP I, LLC SCHEDULE 13G filed by Upstream Bio Inc.Schedule 13G
- 2025-02-13HBM Healthcare Investments (Cayman) Ltd. SCHEDULE 13G filed by Upstream Bio Inc.Schedule 13G
Questions about UPB ownership
- Who owns UPB stock?
- 149 institutional investment managers reported UPB positions in their Form 13F filings for Q2 2026, holding 50,573,705 shares worth $350M in total. FMR LLC reported the largest position.
- Are funds buying or selling UPB?
- In Q2 2026, 37 managers opened new UPB positions, 65 added, 28 trimmed and 28 sold out. Managers that filed in both quarters added a net 5,689,204 shares.
- How current is this UPB institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to UPB by CUSIP. Options are left out. UPB news and filings · UPB insider trades · Top funds